antidiabetic

Type 2 diabetes occurs when the body becomes resistant to insulin or doesn't make enough insulin. The major treatment approach for diabetes is the use of synthetic drugs and insulin. However the side effects associated with the use of synthetic agents attracts the attention of drug discovery professionals to search an effective treatment using natural products. Malaysian plants and herbs have been used as medicinal agents and studies have proved their significance in the treatment of diabetes.  As the fruits of Gnetum gnemon (family: Gnetacea) locally known as melinjo are traditionally used to control diabetes by Malaysian and Indonesian tribes, the present study was aimed to evaluate the folklore claim about G. gnemon fruits to treat diabetes. Hexane extract (GGHE), chloroform extract (GGCE), ethanol extract (GGEE) and water extract (GGWE) were obtained by successive extraction using soxhlet extractor. The preliminary phytochemical analysis was carried out to perceive phytoconstituents in G. gnemon extracts. Diabetes was induced in albino rats by single dose of streptozotocin (60 mg/kg b.wt. i.p.) followed by nicotinamide (120 mg/kg b.wt. i.p.). Streptozotocin-induced diabetic rats were separately treated with GGHE, GGCE, GGEE and GGWE at dose of 400 mg/kg b.wt. and standard drug, glibenclamide (10mg/kg) respectively by oral administration for 14 days and antidiabetic potential of the extracts were assessed. Prelimary phytochemical screening showed the presence of flavonoids, terpenoids, phenolic compounds and tannins. Oral administration of diabetic rats exhibited significant (P

The present study scrutinizes the antidiabetic and the antidiarrhoeal effects of ethanolic extracts of  Ficus racemosa L. stem barks (EEFB) in Wistar rats. Oral glucose tolerance test (OGTT) model and alloxan induced diabetic model (AIDM) were performed to assess antidiabetic activity of EEFB at doses of 750mg/kg, 500 mg/kg and 250 mg/kg, and 2g/ kg respectively. For antidiarrhoeal effects of EEFB, castor oil-induced diarrhoeal (COID) model and gastrointestinal motility test with barium sulphate milk (BSM) model were also assessed at doses of 750 mg/kg and 500 mg/kg, and 250mg/kg respectively. Administration of EEFB resulted low blood glucose levels in OGTT model at doses 750 mg/kg and 500 mg/kg significantly (P